Literature DB >> 22722907

Role of microglia and astrocyte in central pain syndrome following electrolytic lesion at the spinothalamic tract in rats.

Kobra Naseri1, Elham Saghaei, Fatemeh Abbaszadeh, Mina Afhami, Ali Haeri, Farzaneh Rahimi, Masoumeh Jorjani.   

Abstract

Central pain syndrome (CPS) is a debilitating state and one of the consequences of spinal cord injury in patients. Many pathophysiological aspects of CPS are not well documented. Spinal glia activation has been identified as a key factor in the sensory component of chronic pain. In this study, the role of glial subtypes in the process of CPS induced by unilateral electrolytic lesion of spinothalamic tract (STT) is investigated. Male rats received a laminectomy at T8-T9 and then unilateral electrolytic lesion centered on the STT. Thermal and mechanical thresholds as well as locomotor function were measured on days 0, 3, 7, 14, 21, and 28 post-injuries by tail flick, von Frey filament, and open field tests, respectively. To investigate the spinal glial activation following denervation in STT-lesioned groups, Iba1 and GFAP were detected by immunohistochemistry and Western blotting at the same time points. Data showed that STT lesion significantly decreased thermal pain at day 3 in comparison with sham groups. Significant bilateral allodynia appeared in hind paws at day 14 after spinal cord injury and continued to day 28 (P < 0.05). Additionally, electrolytic spinal lesion attenuated locomotor function of injured animals after 7 days (P < 0.05). In both histological assessments and Western blotting, Iba1 increased at days 3 and 7 while increased GFAP occurred from day 14 to 28 after lesion. It appears that microglial activation is important in the early stages of pain development and astrocytic activation occurs later. These events may lead to behavioral outcomes especially central neuropathic pain.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22722907     DOI: 10.1007/s12031-012-9840-3

Source DB:  PubMed          Journal:  J Mol Neurosci        ISSN: 0895-8696            Impact factor:   3.444


  41 in total

Review 1.  Actions of estrogens on glial cells: Implications for neuroprotection.

Authors:  María-Angeles Arevalo; María Santos-Galindo; María-José Bellini; Iñigo Azcoitia; Luis M Garcia-Segura
Journal:  Biochim Biophys Acta       Date:  2009-10-07

Review 2.  Role of microglia in neurotrauma.

Authors:  David J Loane; Kimberly R Byrnes
Journal:  Neurotherapeutics       Date:  2010-10       Impact factor: 7.620

3.  Abnormal activity of primary somatosensory cortex in central pain syndrome.

Authors:  Raimi L Quiton; Radi Masri; Scott M Thompson; Asaf Keller
Journal:  J Neurophysiol       Date:  2010-07-21       Impact factor: 2.714

4.  Propentofylline attenuates allodynia, glial activation and modulates GABAergic tone after spinal cord injury in the rat.

Authors:  Young Seob Gwak; Eric D Crown; Geda C Unabia; Claire E Hulsebosch
Journal:  Pain       Date:  2008-03-18       Impact factor: 6.961

5.  Quantitative real-time RT-PCR assessment of spinal microglial and astrocytic activation markers in a rat model of neuropathic pain.

Authors:  F Y Tanga; V Raghavendra; J A DeLeo
Journal:  Neurochem Int       Date:  2004 Jul-Aug       Impact factor: 3.921

6.  Evidence for activation of astrocytes via reactive microglial cells following hypoglossal nerve transection.

Authors:  M Svensson; N P Eriksson; H Aldskogius
Journal:  J Neurosci Res       Date:  1993-07-01       Impact factor: 4.164

7.  Zona incerta: a role in central pain.

Authors:  Radi Masri; Raimi L Quiton; Jessica M Lucas; Peter D Murray; Scott M Thompson; Asaf Keller
Journal:  J Neurophysiol       Date:  2009-04-29       Impact factor: 2.714

8.  Effect of 17beta-estradiol on functional outcome, release of cytokines, astrocyte reactivity and inflammatory spreading after spinal cord injury in male rats.

Authors:  Marie-Françoise Ritz; Oliver N Hausmann
Journal:  Brain Res       Date:  2008-02-13       Impact factor: 3.252

Review 9.  Mechanisms of chronic central neuropathic pain after spinal cord injury.

Authors:  Claire E Hulsebosch; Bryan C Hains; Eric D Crown; Susan M Carlton
Journal:  Brain Res Rev       Date:  2008-12-25

10.  Microglia-specific localisation of a novel calcium binding protein, Iba1.

Authors:  D Ito; Y Imai; K Ohsawa; K Nakajima; Y Fukuuchi; S Kohsaka
Journal:  Brain Res Mol Brain Res       Date:  1998-06-01
View more
  5 in total

1.  BDNF Overexpression Exhibited Bilateral Effect on Neural Behavior in SCT Mice Associated with AKT Signal Pathway.

Authors:  Mei-Rong Chen; Ping Dai; Shu-Fen Wang; Shu-Hua Song; Hang-Ping Wang; Ya Zhao; Ting-Hua Wang; Jia Liu
Journal:  Neurochem Res       Date:  2016-06-09       Impact factor: 3.996

2.  Estradiol attenuates spinal cord injury-related central pain by decreasing glutamate levels in thalamic VPL nucleus in male rats.

Authors:  Asieh Naderi; Ali Reza Asgari; Reza Zahed; Ali Ghanbari; Razieh Samandari; Masoumeh Jorjani
Journal:  Metab Brain Dis       Date:  2014-05-31       Impact factor: 3.584

3.  In vivo microdialysis of glutamate in ventroposterolateral nucleus of thalamus following electrolytic lesion of spinothalamic tract in rats.

Authors:  A Ghanbari; A R Asgari; G R Kaka; H R Falahatpishe; A Naderi; M Jorjani
Journal:  Exp Brain Res       Date:  2013-11-02       Impact factor: 1.972

Review 4.  Molecular Mechanisms of Astaxanthin as a Potential Neurotherapeutic Agent.

Authors:  Eshak I Bahbah; Sherief Ghozy; Mohamed S Attia; Ahmed Negida; Talha Bin Emran; Saikat Mitra; Ghadeer M Albadrani; Mohamed M Abdel-Daim; Md Sahab Uddin; Jesus Simal-Gandara
Journal:  Mar Drugs       Date:  2021-04-03       Impact factor: 5.118

5.  Microglial deactivation by adeno-associated virus expressing small-hairpin GCH1 has protective effects against neuropathic pain development in a spinothalamic tract-lesion model.

Authors:  Hyun Ho Jung; Chin Su Koh; Minkyung Park; Ji Hyun Kim; Ha-Na Woo; Heuiran Lee; Jin Woo Chang
Journal:  CNS Neurosci Ther       Date:  2021-11-29       Impact factor: 5.243

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.